The NYSE Arca Pharmaceutical Index (DRG) is a market capitalization weighted index
designed to represent a cross section of widely held, highly capitalized companies involved in
various phases of the development, production, and marketing of pharmaceuticals. The index
value was split 2-for-1 on March 23, 1999.